Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.
Champlin
R
R
Department of Blood and Marrow Transplantation, University of Texas-MD Anderson Cancer Center, Houston 77030, USA. rchampli@mdacc.tmc.edu
Khouri
I
I
Shimoni
A
A
Gajewski
J
J
Kornblau
S
S
Molldrem
J
J
Ueno
N
N
Giralt
S
S
Anderlini
P
P
D016026:Bone Marrow Transplantation / Q000379:methods*; D006086:Graft vs Host Disease; D020544:Graft vs Leukemia Effect; D020350:Graft vs Tumor Effect; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008223:Lymphoma / Q000628:therapy*; D013601:T-Lymphocytes / Q000637:transplantation; D014184:Transplantation, Homologous